Dementia is a sensitive topic and one of the health conditions that people are most afraid of. It’s also a daunting area for early stage investors to identify what technologies have the potential to create meaningful and lasting change. For example, how do you assess investing in earlier diagnostic technology if there are no apparent effective therapeutics?
